A Multifunctional Nucleic Acid Nanomedicine Coregulates Angiogenesis and Fibrosis to Treat Oral Submucous Fibrosis
Small · 2026
DOI: 10.1002/smll.74277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Xiao Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China. Hauptthemen laut MEDLINE: Oral Submucous Fibrosis, Nucleic Acids, Nanomedicine, Neovascularization, Pathologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Academic Enhancement Support Program of Hainan Medical University, Hainan Province Science and Technology Special Fund, Clinical Translational Innovation Cultivating Fund 550 Project of Hainan General Hospital.
Abstract (Originalsprache)
Oral submucous fibrosis (OSF) is a chronic progressive oral fibrotic disorder characterized by dysregulated immune inflammation, fibroblast activation, and vascular homeostasis disruption, yet synchronously regulating these axes remains challenging. We developed a multifunctional nucleic acid nanomedicine, Apt02–tFNAs–siTGF‐β (A‐T‐S), in which tetrahedral framework nucleic acids co‐deliver siRNA against TGF‐β (siTGF‐β) and the proangiogenic aptamer Apt02, enabling programmable integration and stable delivery. A‐T‐S was efficiently internalized by macrophages, human oral mucosal fibroblasts, and endothelial cells and concurrently modulated inflammatory phenotypes, fibrotic programs, and angiogenesis‐related features in vitro. Transcriptomic profiling revealed coordinated reprogramming of pathways involved in inflammation, fibrosis, and extracellular matrix remodeling. In a rat OSF model, A‐T‐S reduced collagen deposition and profibrotic signaling while mitigating inflammatory infiltration and vascular abnormalities, without evident toxicity in major organs. These findings indicate that A‐T‐S can synergistically remodel the OSF lesion microenvironment and represents a promising strategy for OSF and other fibroinflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
- State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
- Affiliated Stomatology Hospital of Guilin Medical University, Guilin, China.
- Macao Translational Medicine Center, Macau University of Science and Technology, Taipa, Macau SAR, China.
ORCID-Profile: Mei Zhang, Yunfeng Lin
Förderung
- Academic Enhancement Support Program of Hainan Medical University
- Hainan Province Science and Technology Special Fund
- Clinical Translational Innovation Cultivating Fund 550 Project of Hainan General Hospital
- Program on Health Science & Technology Innovation of Hainan Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program Grade C of China Postdoctoral Science Foundation
Zitieren
APA
Fu, X., Zhang, M., Xiong, J., Ma, J., Cui, W., He, Y., Lin, Y., & Wang, T. (2026). A Multifunctional Nucleic Acid Nanomedicine Coregulates Angiogenesis and Fibrosis to Treat Oral Submucous Fibrosis. Small. https://doi.org/10.1002/smll.74277
Vancouver
Fu X, Zhang M, Xiong J, Ma J, Cui W, He Y, et al. A Multifunctional Nucleic Acid Nanomedicine Coregulates Angiogenesis and Fibrosis to Treat Oral Submucous Fibrosis. Small. 2026. doi:10.1002/smll.74277
BibTeX
@article{Fu2026,
author = {Fu, Xiao and Zhang, Mei and Xiong, Jiahui and Ma, Junhui and Cui, Wuxiao and He, Yao and Lin, Yunfeng and Wang, Tao},
title = {A Multifunctional Nucleic Acid Nanomedicine Coregulates Angiogenesis and Fibrosis to Treat Oral Submucous Fibrosis},
journal = {Small},
year = {2026},
doi = {10.1002/smll.74277}
}
EUVIMED